AstraZeneca will host a roundtable at Parliament House in Canberra today. The discussion will focus on a proposal to introduce an Interim Cancer Fund as a bridge for patients to access cancer medicines while they navigate Australia's health technology assessment process.
AstraZeneca roundtable to highlight push for Australian Interim Cancer Fund
March 20, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
NSW Premier opens Australia’s first large-scale health translation hub at UNSW
November 24, 2025 - - Latest News -
Cynata completes final patient visits in pivotal Phase 3 osteoarthritis trial
November 24, 2025 - - Australian Biotech -
New review recommends a balanced and measured approach to adopting AI in clinical practice
November 24, 2025 - - BioPharma -
Sanofi becomes first tenant of ENTRI, marking major step for Queensland’s translational research ambitions
November 24, 2025 - - Latest News -
Moderna names CSIRO scientist Dr Anne Klein as 2025 Australian Fellow
November 24, 2025 - - Australian Biotech -
‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma
November 24, 2025 - - Latest News -
New national report warns of deepening ovarian cancer burden and calls for urgent action
November 24, 2025 - - Latest News
